Name: Zoom Seminar Series
Start: 2021-07-30T13:30:00-04:00
End: 2021-07-30T14:30:00-04:00
Location: Zoom Seminar Series

The Center for Virology and Vaccine Research (CVVR) at Beth Israel Deaconess Medical Center aims to promote research and education activities related to virology, vaccinology, and related disciplines, including basic, translational, and clinical vaccine research. The Center consists of primary and affiliate faculty and focuses on the development of vaccines against infectious, oncologic, degenerative, and other diseases.

Research Programs

CVVR Clinical Trials

The mission of the CVVR Clinical Trials Unit is the development of novel preventive and therapeutic approaches to viral illnesses such as Human Immunodeficiency Virus (HIV), Zika Virus and COVID-19.

Learn more >

Join the Volunteer Registry

Core Facilities

Flow Cytometry Core

The Flow Cytometry Core facility provides equipment, and consultation and data analysis services by dedicated personnel to both in-house and outside researchers. Areas of expertise include non-human primate (NHP) and infectious disease research. The Flow Cytometry Core is committed to providing the latest software and equipment to better assist peer researchers. The Flow Cytometry Core facility is affiliated with Harvard University and is supported by the NIH Center for AIDS Research (CFAR).
Learn more >

Harvard Catalyst-red on white

Harvard Catalyst Clinical Research Center

The Harvard Catalyst Clinical Research Center (CRC) is a core facility provided to all Beth Isreal Deaconess Medical Center investigators as well as affiliated Harvard faculty for the conduct of clinical trials. The CRC provides contiguous space for inpatient, outpatient, and administrative support activities and is located at BIDMC. CRC staff includes nurses, dieticians, a laboratory assistant, and a unit coordinator. The unit is open for patient activity 24 hours per day, seven days per week.

HIV-1 Neutralizing Antibody Core

The HIV-1 Neutralizing Antibody Core provides in vitro HIV-1 neutralizing antibody assay services to BIDMC and the external research community. The core is GCLP-compliant; it serves as a resource for assessing the breadth and potency of HIV-1 neutralizing antibodies, and for characterizing the neutralization phenotype of HIV-1 isolates.
Learn more >

CVVR Academic Program

In addition to material and technical support, the Center for Virology and Vaccine Research offers a rich intellectual environment for early stage investigators and students. CVVR hosts weekly meetings for its postdoctoral fellows and graduate students to discuss ongoing work, as well as bi-monthly journal club lunches and weekly CVVR seminars with invited speakers. All postdoctoral fellows and junior faculty are encouraged to submit abstracts and to attend conferences and other professional meetings.

Learn more >

Young Investigators

The Young Investigator Committee identifies critical issues affecting young and early career investigators working within CVVR. The Committee connects junior faculty, senior postdoctoral fellows, and other researchers with the goal of building fruitful collaborations, finding solutions to the challenges in research, and developing careers.

Learn more >

Calendar of Events

Fri 25

Asymptomatic CMV and Aging-related Complications in Treated HIV

June 25 @ 1:30 pm - 2:30 pm

Jul 09

Zoom Seminar Series

July 9 @ 1:30 pm - 2:30 pm

Jul 16

Zoom Seminar Series

July 16 @ 1:30 pm - 2:30 pm

Jul 23

Zoom Seminar Series

July 23 @ 1:30 pm - 2:30 pm

Jul 30

Zoom Seminar Series

July 30 @ 1:30 pm - 2:30 pm

News and Events

All/CVVR Events/News

ABCNEWS

2021-06-10/by Morgana Souza

We know vaccines are working against new COVID variants. Now scientists are starting to understand why.

After months of research, experts are seeing positive results. Read Article

NPR

2021-06-09/by Morgana Souza

New Evidence Suggests COVID-19 Vaccines Remain Effective Against Variants

The emergence of new and more infectious variants of the coronavirus has raised a troubling question: Will the current crop of COVID-19 vaccine prevent these variants from causing disease? Listen…

USA TODAY

2021-06-09/by Morgana Souza

Johnson & Johnson COVID-19 vaccine protects against virus variants, study shows

Johnson & Johnson's COVID-19 vaccine triggers several types of immune responses, a new study shows, allowing it to be extremely protective in the United States as well as in South Africa…

2021-06-09/by Morgana Souza

Mixing COVID-19 vaccines appears to boost immune responses

n three recent studies, researchers have found that following one dose of the vaccine made by AstraZeneca with a dose of the Pfizer-BioNTech vaccine produces strong immune responses, as measured…

Boston Globe

2021-06-09/by Morgana Souza

Why does the Johnson & Johnson vaccine work against variants? A new study suggests an answer

New research suggests that Johnson & Johnson’s single-dose COVID-19 vaccine provides protection against worrisome virus variants — but perhaps not for the reasons researchers originally…

2021-06-07/by Morgana Souza

U.S. Moves Closer To Biden’s July 4 COVID-19 Vaccination Goal

U.S. COVID-19 cases have dropped 95% since January. At least 65% of adults have had a least one vaccine shot. President Biden aims to have 70% of adults vaccinated with at least one shot by July…

CNN

2021-06-05/by Morgana Souza

Caught in a ‘pickle,’ millions of Americans might not have had an adequate response to the Covid-19 vaccine

"It's become such a frequent question, such a point of anxiety for patients, that last week we had three different meetings and conferences and seminars all taking about this and trying to figure…

ABCNEWS

2021-05-26/by Morgana Souza

US health agencies will decide if COVID-19 booster shots are needed – not vaccine companies

It is still unknown if and when a COVID-19 booster shot might be needed. Read Article

Nature

2021-05-19/by Morgana Souza

Mix-and-match COVID vaccines trigger potent immune response

Preliminary results from a trial of more than 600 people are the first to show the benefits of combining different vaccines. Read Article

Discover magazine

2021-05-18/by Morgana Souza

Why It’s Harder For Many Transgender People To Access (And Trust) COVID-19 Vaccines

The medical field has historically neglected and abused trans people, while also overlooking them in clinical trials. Despite community skepticism, LGBTQ people overall are more likely to view…

2021-05-14/by Morgana Souza

Are they experimental? Can they alter DNA? Experts tackle lingering coronavirus vaccine fears.

How can the vaccines be safe and effective if they were developed so quickly? Read Article

Boston Globe

2021-05-13/by Morgana Souza

Pfizer and Moderna vaccines produce robust immune responses in women who are pregnant or nursing

The findings come from a small study conducted at Beth Israel Deaconess in Boston. Read Article

NYT

2021-05-13/by Morgana Souza

Coronavirus Vaccines Protect Pregnant Women, Another Study Suggests

The shots may also have benefits for infants and do not seem to damage the placenta, according to the latest research. Read Article

2021-03-03/by Morgana Souza

Thank you from Lehigh University- Dr. Tartaglia & class

2020-06-18/by Morgana Souza

2020 ID Division Awards

2020-06-12/by Morgana Souza

Secretary Azar, Gov. Charlie Baker, Lt. Gov Polito, and Mass HHS Secretary Sudders visit to BIDMC

Governor Charlie Baker, Lt. Governor Karyn Polito and U.S. Secretary of Health and Human Services Alex Azar joined Dr. Barouch for an important discussion about our COVID-19 vaccine response.…

2019-12-18/by Academic Web Pages

Medical All-Stars

The Boston Red Sox honored Dr.Stephenson on June 7th,2019 as a Medical All-Star for her work in the HIV research field.

2019-12-18/by Academic Web Pages

2019 CVVR Visiting Professor

We were honored to have Dr. Robert Siliciano, MD, PhD. join us for our annual visiting professor this year.

2019-06-25/by Academic Web Pages

2019 Boston Pride Parade

Members of CVVR joined Team BIDMC for the 2019 Boston Pride Parade.

2019-06-18/by Academic Web Pages

2019 Boston AIDS Walk

Members of the CVVR joined TEAM BIDMC for the 2019 Aids Walk, which is the largest HIV/AIDS awareness event in New England.

2019-03-07/by Academic Web Pages

Conference on Retrovirus and Opportunistic Infections 2019

“The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies,…

2018-12-18/by Academic Web Pages

2018 Reeves’ Annual Winter Employee Event

2018 Reeve's Annual Winter Employee Event

2018-11-18/by Academic Web Pages

2018 CVVR Visiting Professor

We were honored to have COL. Nelson Michael join us this year as our 2018 visiting professor.

2018-06-03/by Academic Web Pages

2018 AIDS Walk & Run Boston

Dr. Dan Barouch with Mayor Marty Walsh at the Annual 2018 AIDS Walk and Run.

2017-07-07/by Academic Web Pages

Visit from Buckingham Browne & Nichols School

ABCNEWS

2021-06-10/by Morgana Souza

We know vaccines are working against new COVID variants. Now scientists are starting to understand why.

After months of research, experts are seeing positive results. Read Article

NPR

2021-06-09/by Morgana Souza

New Evidence Suggests COVID-19 Vaccines Remain Effective Against Variants

The emergence of new and more infectious variants of the coronavirus has raised a troubling question: Will the current crop of COVID-19 vaccine prevent these variants from causing disease? Listen…

USA TODAY

2021-06-09/by Morgana Souza

Johnson & Johnson COVID-19 vaccine protects against virus variants, study shows

Johnson & Johnson's COVID-19 vaccine triggers several types of immune responses, a new study shows, allowing it to be extremely protective in the United States as well as in South Africa…

2021-06-09/by Morgana Souza

Mixing COVID-19 vaccines appears to boost immune responses

n three recent studies, researchers have found that following one dose of the vaccine made by AstraZeneca with a dose of the Pfizer-BioNTech vaccine produces strong immune responses, as measured…

Boston Globe

2021-06-09/by Morgana Souza

Why does the Johnson & Johnson vaccine work against variants? A new study suggests an answer

New research suggests that Johnson & Johnson’s single-dose COVID-19 vaccine provides protection against worrisome virus variants — but perhaps not for the reasons researchers originally…

2021-06-07/by Morgana Souza

U.S. Moves Closer To Biden’s July 4 COVID-19 Vaccination Goal

U.S. COVID-19 cases have dropped 95% since January. At least 65% of adults have had a least one vaccine shot. President Biden aims to have 70% of adults vaccinated with at least one shot by July…

CNN

2021-06-05/by Morgana Souza

Caught in a ‘pickle,’ millions of Americans might not have had an adequate response to the Covid-19 vaccine

"It's become such a frequent question, such a point of anxiety for patients, that last week we had three different meetings and conferences and seminars all taking about this and trying to figure…

ABCNEWS

2021-05-26/by Morgana Souza

US health agencies will decide if COVID-19 booster shots are needed – not vaccine companies

It is still unknown if and when a COVID-19 booster shot might be needed. Read Article

Nature

2021-05-19/by Morgana Souza

Mix-and-match COVID vaccines trigger potent immune response

Preliminary results from a trial of more than 600 people are the first to show the benefits of combining different vaccines. Read Article

Discover magazine

2021-05-18/by Morgana Souza

Why It’s Harder For Many Transgender People To Access (And Trust) COVID-19 Vaccines

The medical field has historically neglected and abused trans people, while also overlooking them in clinical trials. Despite community skepticism, LGBTQ people overall are more likely to view…

2021-05-14/by Morgana Souza

Are they experimental? Can they alter DNA? Experts tackle lingering coronavirus vaccine fears.

How can the vaccines be safe and effective if they were developed so quickly? Read Article

Boston Globe

2021-05-13/by Morgana Souza

Pfizer and Moderna vaccines produce robust immune responses in women who are pregnant or nursing

The findings come from a small study conducted at Beth Israel Deaconess in Boston. Read Article

NYT

2021-05-13/by Morgana Souza

Coronavirus Vaccines Protect Pregnant Women, Another Study Suggests

The shots may also have benefits for infants and do not seem to damage the placenta, according to the latest research. Read Article

All News & Events >

Selected Publications

Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women

JAMA, 2021. Read Article

Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19

JAMA, 2021. Read Article

A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine

Ann Intern Med, 2021. Read Article

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

The New England Journal of Medicine, 2021. Read Article

Correlates of protection against SARS-CoV-2 in rhesus macaques

Nature, 2020. Read Article

Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques

Cell, 2020. Read Article

Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters

Nature Medicine, 2020. Read Article

Approaches and Challenges in SARS-CoV-2 Vaccine Development

Cell Host Microbe, 2020. Read Article

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

Nature, 2020. Read Article

SARS-CoV-2 infection protects against rechallenge in rhesus macaques

Science, 2020. Read Article

DNA vaccine protection against SARS-CoV-2 in rhesus macaques

Science, 2020. Read Article

Lack of therapeutic efficacy of an antibody to α4β7 in SIVmac251-infected rhesus macaques.

Science, 2019. Read Article

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).

Lancet, 2018. Read Article

Evidence that CD32a does not mark the HIV-1 latent reservoir.

Nature, 2018. Read Article

Fetal neuropathology in Zika virus-infected pregnant female rhesus monkeys.

Cell, 2018. Read Article

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

Nature, 2018. Read Article

Zika virus persistence in the central nervous system and lymph nodes of rhesus monkeys.

Cell, 2017. Read Article

Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys.

Nature, 2016. Read Article

Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus.

Science, 2016. Read Article

Cryo-EM reveals a novel octameric integrase structure for betaretroviral intasome function.

Nature, 2016. Read Article

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys.

Science, 2016. Read Article

Vaccine protection against Zika virus from Brazil.

Nature, 2016. Read Article

Zika viral dynamics and shedding in rhesus and cynomolgus macaques.

Nat Med., 2016. Read Article

Rapid inflammasome activation following mucosal SIV infection of rhesus monkeys.

Cell, 2016. Read Article

Antigen-specific NK cell memory in rhesus macaques.

Nat. Immunol., 2015. Read Article

All Publications >

Research Programs

Neuro-Virology/Immunology

Translational Immunology

Viral Pathogenesis

CVVR Clinical Trials

Core Facilities

Flow Cytometry Core

Harvard Catalyst Clinical Research Center

HIV-1 Neutralizing Antibody Core

CVVR Academic Program

Young Investigators

Calendar of Events

Center for Virology and Vaccine Research

CVVR Clinical Trials Unit

Affiliates